scholarly journals Enhanced recovery after surgery components and perioperative outcomes: a nationwide observational study

2020 ◽  
Vol 124 (5) ◽  
pp. 638-647 ◽  
Author(s):  
Stavros G. Memtsoudis ◽  
Megan Fiasconaro ◽  
Ellen M. Soffin ◽  
Jiabin Liu ◽  
Lauren A. Wilson ◽  
...  
2020 ◽  
Author(s):  
Mengchen Yin ◽  
Yinjie Yan ◽  
Zhaoxiang Fan ◽  
Niankang Fang ◽  
Hongbo Wan ◽  
...  

Abstract Background: Intertrochanteric fracture (ITF) is increasing with the rapid increase in the aging population, often causes a high mortality rate in old patients and increases the economic burden of the family and society. ERAS (Enhanced Recovery after Surgery) is a powerful guarantee for patients to accelerate their recovery after surgery. TCM (traditional Chinese medicine) promote repair of injured tissues and eliminate traumatic aseptic inflammation. Therefore, this prospective randomized controlled clinical trial aims to evaluate the clinical effect of the evidence-based ERAS pathway of integrating TCM with and western medicine on perioperative outcomes in ITF patients undergoing intramedullary fixation, and provide reliable evidence-based data for applying the program to clinical practice. Methods/design: We will conduct a prospective randomized, blinded, controlled trial to compare the effectiveness of ERAS care pathway with traditional care pathway, and to investigate whether the ERAS care pathway can improve the perioperative outcome in ITF patients undergoing intramedullary fixation. A total of 60 patients with ITF will be enrolled and treated with the two care pathway, respectively. Length of stay, economic indicators, Harris score, VAS score, time get out of bed, 30-day readmission rates, postoperative transfusion rates, discharge to home and mortality will be evaluated. Any signs of acute adverse reactions will be recorded at each visit during treatment. Discussion: Although an evidence-based process using the best available literature and Delphi expert-opinion method has been used to establish an ERAS pathway of integrating TCM with western medicine. But, there is a lack of consensus about its effectiveness. This trial will provide convincing evidence about the effect of ERAS pathway Trial registration: Registered on 12 Oct 2019; Trial number is ChiCTR190t0026487 Keywords: intertrochanteric fracture; enhanced recovery after surgery; perioperative period; integrating TCM with and western medicine; randomized controlled trial


Cancer ◽  
2020 ◽  
Vol 126 (18) ◽  
pp. 4148-4155 ◽  
Author(s):  
Guillaume Ploussard ◽  
Christophe Almeras ◽  
Jean‐Baptiste Beauval ◽  
Jean‐Romain Gautier ◽  
Valérie Garnault ◽  
...  

Author(s):  
Harry Amson ◽  
Philippe Lasselin ◽  
Bertille Naegels ◽  
Gilda Pardey Bracho ◽  
Frédéric Aubrun ◽  
...  

Aim: To evaluate the usability and satisfaction from the sufentanil sublingual tablet system analgesia in the Enhanced Recovery After Surgery pathway in patients, nurses and physical therapist. Materials & methods: A system usability scale was used to evaluate analgesia system in the prospective observational study in spine, orthopedic and thoracic patients. Result: In 111 cases the median system usability scale score was 90 (80–100) (patients) and 72.5 (57.5–82.5) (nurses). The median satisfaction score of the physiotherapist was 90 (75–100). Conclusion: The usability and the satisfaction of the patients and the caregivers from sufentanil sublingual tablet system analgesia in the context of Enhanced Recovery After Surgery protocol were good-to-excellent. The economic potential in the reduction of hospital stay should be studied. Trial registration number: NCT03373851 ( ClinicalTrial.gov )


2020 ◽  
pp. 021849232096643
Author(s):  
Mohan Venkatesh Pulle ◽  
Neha Tiwari ◽  
Belal Bin Asaf ◽  
Harsh Vardhan Puri ◽  
Sukhram Bishnoi ◽  
...  

Background Enhanced recovery after surgery protocols in tuberculous empyema surgery have the potential for improved outcomes, but have not been studied widely. This study aimed to analyze the outcomes after implementation of an enhanced recovery after surgery protocol in patients undergoing surgery for tubercular empyema. Methods A retrospective analysis of patients who underwent surgery for tuberculous empyema in a dedicated thoracic surgery center from March 2012 to March 2019 was performed. The control group included patients operated on between March 2012 and March 2016. The enhanced recovery after surgery protocol was strictly introduced into our practice from April 2016. The study group included patients operated on between April 2016 and March 2019. All perioperative outcomes were measured, documented, analyzed, and compared between the two groups. There were 166 patients in the control group and 77 in the study group. Results Intraoperative blood loss ( p = 0.0001), prolonged air leak ( p = 0.04), chest tube duration ( p = 0.005), and length of stay ( p = 0.003) were significantly reduced in the study group. Overall rates of postoperative complications ( p = 0.04) including wound infection ( p = 0.01) were also significantly lower in the study group. Conclusions Implementation of an enhanced recovery after surgery protocol in patients undergoing surgery for tuberculous empyema is feasible and effective. Application of such a protocol leads to less intraoperative blood loss, shorter hospital stay and duration of chest drainage, and fewer complications. Application of enhanced recovery after surgery protocols are strongly recommended in tubercular empyema surgery.


Sign in / Sign up

Export Citation Format

Share Document